4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

11.32

-0.09 (-0.79%)

Oct 30, 2025, 4:00 PM EDT - Market closed

4D Molecular Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Oct '25 Oct 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	529	257	866	719	705	1,098	Upgrade
Market Cap Growth	14.43%	-70.27%	20.40%	2.03%	-35.79%	-	Upgrade
Enterprise Value	135	-268	562	497	478	1,185	Upgrade
Last Close Price	11.32	5.57	20.26	22.21	21.94	41.45	Upgrade
PS Ratio	16020.36	6959.14	41.80	229.93	39.09	80.68	Upgrade
PB Ratio	1.26	0.50	2.81	3.11	2.21	4.28	Upgrade
P/TBV Ratio	1.26	0.50	2.81	3.11	2.21	4.28	Upgrade
EV/Sales Ratio	4082.36	-	27.10	158.89	26.50	87.05	Upgrade
Debt / Equity Ratio	0.06	0.05	0.05	0.07	0.05	-	Upgrade
Asset Turnover	0	0	0.07	0.01	0.06	0.08	Upgrade
Quick Ratio	8.46	14.58	15.21	13.58	15.21	16.62	Upgrade
Current Ratio	8.75	14.92	15.65	14.02	15.69	16.88	Upgrade
Return on Equity (ROE)	-38.87%	-39.31%	-37.41%	-39.06%	-24.79%	-39.59%	Upgrade
Return on Assets (ROA)	-25.18%	-26.08%	-23.45%	-22.35%	-13.89%	-20.44%	Upgrade
Return on Capital (ROIC)	-26.33%	-27.38%	-24.75%	-23.59%	-15.06%	-24.73%	Upgrade
Earnings Yield	-37.10%	-62.48%	-11.64%	-14.94%	-10.11%	-5.16%	Upgrade
FCF Yield	-32.12%	-53.74%	-9.07%	-13.65%	-11.10%	-4.73%	Upgrade
Buyback Yield / Dilution	-17.47%	-37.86%	-20.95%	-16.66%	-331.23%	-25.05%	Upgrade

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q